Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature.

During the ASCEND-HF trial, dyspnea at 6 hours and 24 hours following treatment with nesiritide, the rate of rehospitalization or death at 30 days was evaluated, which found only a small reduction in dyspnea that did not reach statistical significance [ 41 , 42 ].

also in 111,027 other papers